Bromide

Bromide

SCHEMBL2441814

Br.CC(C)[C@]12CC[C@H](C[C@H](O)C1)N2C

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936714 0.75 SLC6A9 (0.34)
SCHEMBL10355569 0.72 LMNA (0.36) LMNACYP2C9
SCHEMBL4743603 0.71 LMNA (0.40) LMNACYP2C9
SCHEMBL7292447 0.71 LMNA (0.40) LMNACYP2C9
SCHEMBL3997073 0.69 LMNA (0.39) LMNACYP2C9
SCHEMBL503732 0.69 LMNA (0.35) LMNACYP2C9
SCHEMBL8781384 0.69 LMNA (0.35) LMNACYP2C9
SCHEMBL1638503 0.68 LMNA (0.38) LMNACYP2C9
SCHEMBL5493343 0.68 LMNA (0.34) LMNACYP2C9
SCHEMBL7349981 0.66 LMNA (0.32) LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120294938-A1 PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN THE SMALL INTESTINE AND METHOD FOR ITS PRODUCTION Dr. R. Pflefger Chemische Fabrik GmbH (DE) 2012-11-22 US claimed
EP-1880718-B1 Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof PFLEGER R CHEM FAB (DE) 2011-09-21 EP claimed
US-20090285891-A1 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production DR. R. PFLEGER CHEMISCHE FABRIK GMBH (DE) 2009-11-19 US claimed
US-20120294938-A1 PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN THE SMALL INTESTINE AND METHOD FOR ITS PRODUCTION Dr. R. Pflefger Chemische Fabrik GmbH (DE) 2012-11-22 US disclosed
US-8221787-B2 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production Dr. Robert Pfleger Chemische Fabrik GmbH (DE) 2012-07-17 US disclosed
US-20090285891-A1 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production DR. R. PFLEGER CHEMISCHE FABRIK GMBH (DE) 2009-11-19 US disclosed